阿是穴刺血治疗急性痛风近远期临床观察

目的观察阿是穴刺血对急性痛风及后期痛风石形成的影响。方法将90例患者随机分为两组,治疗组45例采用阿是穴刺血,对照组45例先服双氯芬酸钠缓释胶囊,待疼痛症状控制后改服苯溴马隆片,于治疗21 d后比较两组临床疗效及血尿酸浓度的变化,3个月后比较两组痛风石的形成情况。结果治疗组与对照组愈显率分别为86.7%和55.6%,两组比较差异具有统计学意义(P<0.05);两组治疗后血尿酸浓度均有下降(P<0.01)。两组治疗后血尿酸浓度组间比较,差异无统计学意义(P>0.05),即两组的血尿酸浓度降低大致相近;两组治疗前后痛风石的形成病例数比较均有上升。组间比较,差异具有统计学意义(P<0.01),即治疗组痛风石的形成明显少于对照组。结论阿是穴刺血在治疗急性痛风及预防痛风石的形成方面具有明显的疗效,优于西药治疗。

Clinical Observations on the Short-term and Long-term Effect of Pricking Bloodletting at Ashi Points in the Treatment of Acute Gout

Objective To investigate the effect of pricking bloodletting at ashi points on acute gout and late formation of tophi. Method Ninety patients were randomly allocated to two groups. The treatment group of 45 patients received pricking bloodletting at ashi points. The control group of 45 patients first took diclofenac sodium sustained-release capsules and changed to taking benzbromarone tablets after the pain was controlled. The therapeutic effects and blood uric acid concentrations were compared between the two groups at 21 days after treatment. The states of tophi were compared between the two groups at 3 months after treatment. Result The cure and marked efficacy rate were 86.7% in the treatment group and 55.6% in the control group; there was a statistically significant difference between the two groups （P〈0.05）. Blood uric acid concentrations decreased in both groups after treatment. There was no statistically significant post-treatment difference in blood uric acid concentrations between the two groups （P〉0.05）, that is, the two groups were close in blood uric acid concentrations. The number of patients with tophus formation increased in both groups after treatment. There was a statistically significant difference between the groups （P〈0.01）, that is, tophus formation occurred significantly less in the treatment group than in the control group. Conclusion Pricking bloodletting at ashi points is remarkably effective and superior to Western drug treatment in treating acute gout and preventing tophus formation.